molbiz | The „COLD-PCR approach“ for early and cost-effective detection of tyrosine kinase inhibitor resistance mutations in EGFR-positive non-small cell lung cancer

+++Sicherheitsinformation: Aufgrund der aktuellen Bedrohung durch Computerviren werden derzeit alle ANHÄNGE von eingehenden E-Mails automatisch entfernt. Unterlagen übersenden Sie uns daher bitte bis auf Weiteres auf dem Postweg oder per Fax.+++

The „COLD-PCR approach“ for early and cost-effective detection of tyrosine kinase inhibitor resistance mutations in EGFR-positive non-small cell lung cancer

The „COLD-PCR approach“ for early and cost-effective detection of tyrosine kinase inhibitor resistance mutations in EGFR-positive non-small cell lung cancer

Mairinger FD, Vollbrecht C, Streubel A, Roth A, Landt O, Walter HF, Kollmeier J, Mairinger T. :The „COLD-PCR approach“ for early and cost-effective detection of tyrosine kinase inhibitor resistance mutations in EGFR-positive non-small cell lung cancer. Appl Immunohistochem Mol Morphol. 2014;22(2):114-8

Content

The „COLD-PCR approach“ for early and cost-effective detection of tyrosine kinase inhibitor resistance mutations in EGFR-positive non-small cell lung cancer